LTI-03 — Topline data
Q4 2026
We expect to report initial interim topline data on some proportion of patients in the fourth quarter of 2026.Source filing
RNTX biotech catalysts & pipeline
REIN THERAPEUTICS INC · Data as of 2026-10-25
catalyst calendar
/